Science
The Most Clinically Proven Vitamin K2, MenaQ7®
Backed by more than 22 trials, trusted by renowned experts
Being able to say an ingredient is clinically validated takes an overwhelming investment and commitment, which is the exact course that has shaped the MenaQ7® Vitamin K2 as MK-7 on the market today.
Today’s understanding of Vitamin K2 is based solely on MenaQ7®, the source material for more than 22 human clinical trials (with more underway) demonstrating safe, efficacious benefits for human health. And those studies were published in respected peer-reviewed journals:
MenaQ7® and Cardiovascular Health
- Liv M. Vossen, et. al. JAMA Cardiology . 2026.
- Vermeer C and Vik H. Vascular Diseases and Therapeutics. 2020
- Mansour et al. Journal of the American Society of Hypertension. 2017
- Aoun et al. BMC Nephrology. 2017
- Knapen et al. European Journal of Clinical Nutrition. 2016
- Knapen et al. Journal of Nutritional Science. 2015
- Kurnatowska et al. Polish Archives of Internal Medicine. 2015
- Knapen et al. Thrombosis and Haemostasis. 2015
- Theuwissen et al. British Journal of Nutrition. 2012
- Chatrou et al. Blood Review. 2012
- Dalmeijer et al. Atherosclerosis. 2012
MenaQ7® in Diseased Populations
- Mansour et al. Journal of the American Society of Hypertension. 2017
- Aoun et al. BMC Nephrology. 2017
- Kurnatowska et al. Polish Archive of Internal Medicine, 2015
- Calwue et al. Nephrology Dialysis Transplant. 2014
- Ozdemir et al. Journal Pediatric Hematology Oncology. 2013
- Westenfeld et al. American Journal of Kidney Disease. 2012
MenaQ7® in Healthy Populations and Children’s Health
MenaQ7® for Optimal Bioavailability
This commitment to scientific research and clinical validation has earned MenaQ7® the VitaK2™ Seal of Quality and Efficacy from the world’s leading experts in vitamin K.
MenaQ7® is featured in quality products around the globe.
